Abstract

BackgroundCircular RNAs (circRNAs) have been considered as pivotal biomarkers in Diabetic nephropathy (DN). CircRNA ARP2 actin-related protein 2 homolog (circ-ACTR2) could promote the HG-induced cell injury in DN. However, how circ-ACTR2 acts in DN is still unclear. This study aimed to explore the molecular mechanism of circ-ACTR2 in DN progression, intending to provide support for the diagnostic and therapeutic potentials of circ-ACTR2 in DN.MethodsRNA expression analysis was conducted by the quantitative reverse transcription-polymerase chain reaction (qRT-PCR). Cell growth was measured via Cell Counting Kit-8 and EdU assays. Inflammatory response was assessed by Enzyme-linked immunosorbent assay. The protein detection was performed via western blot. Oxidative stress was evaluated by the commercial kits. The molecular interaction was affirmed through dual-luciferase reporter and RNA immunoprecipitation assays.ResultsCirc-ACTR2 level was upregulated in DN samples and high glucose (HG)-treated human renal mesangial cells (HRMCs). Silencing the circ-ACTR2 expression partly abolished the HG-induced cell proliferation, inflammation and extracellular matrix accumulation and oxidative stress in HRMCs. Circ-ACTR2 was confirmed as a sponge for miR-205-5p. Circ-ACTR2 regulated the effects of HG on HRMCs by targeting miR-205-5p. MiR-205-5p directly targeted high-mobility group AT-hook 2 (HMGA2), and HMGA2 downregulation also protected against cell injury in HG-treated HRMCs. HG-mediated cell dysfunction was repressed by miR-205-5p/HMGA2 axis. Moreover, circ-ACTR2 increased the expression of HMGA2 through the sponge effect on miR-205-5p in HG-treated HRMCs.ConclusionAll data have manifested that circ-ACTR2 contributed to the HG-induced DN progression in HRMCs by the mediation of miR-205-5p/HMGA2 axis.

Highlights

  • Diabetic nephropathy (DN) is a serious complication resulting from diabetes mellitus (DM) in kidney, and it has become the main cause of chronic kidney disease or end-stage renal failure [1, 2]

  • The high expression of circ‐ACTR2 was detected in DN samples and high glucose (HG)‐treated human renal mesangial cells (HRMCs) The expression pattern of circ-ACTR2 was examined by quantitative reverse transcription-polymerase chain reaction (qRT-PCR) in tissue samples and cells

  • HG treatment induced the upregulation of circ-ACTR2 in HRMCs contrasted with the control group (Fig. 1B)

Read more

Summary

Introduction

Diabetic nephropathy (DN) is a serious complication resulting from diabetes mellitus (DM) in kidney, and it has become the main cause of chronic kidney disease or end-stage renal failure [1, 2]. Mesangial cells play important roles in the pathogenesis of DN [3, 4]. To explore the molecular mechanism of mesangial cell dysfunction is important for the treatment of DN. Glycated albumin has been considered to act as a biomarker to predict the cardiovascular risk of DM [8] and evaluate glycemic status in patients with advanced chronic kidney disease [9]. Circular RNAs (circRNAs) have been considered as pivotal biomarkers in Diabetic nephropathy (DN). CircRNA ARP2 actin-related protein 2 homolog (circ-ACTR2) could promote the HG-induced cell injury in DN. This study aimed to explore the molecular mechanism of circ-ACTR2 in DN progression, intending to provide support for the diagnostic and therapeutic potentials of circ-ACTR2 in DN

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call